12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children: the REALITY trial
雷特格韦
医学
病毒载量
抗逆转录病毒疗法
病毒学
人类免疫缺陷病毒(HIV)
作者
C. Kityo,Abraham Siika,AJ Szubert,Jane Mallewa,Mutsa Bwakura‐Dangarembizi,Sheila Kabahenda,Shalton Mwaringa,SL Pett,Anna Griffiths,Abbas Lugemwa,S Wachira,Godfrey Musoro,C Rajapakse,Anthony Etyang,James Abach,Priscilla Wavamunno,L Nyondo-Mipando,Andrea E. Reid,Kusum Nathoo,James Hakim,D.M. Gibb,A S Walker,Team Realityt.